Page last updated: 2024-10-24

carvedilol and Carcinogenesis

carvedilol has been researched along with Carcinogenesis in 1 studies

Carcinogenesis: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.

Research Excerpts

ExcerptRelevanceReference
"Recent studies suggest that the β-blocker drug carvedilol prevents skin carcinogenesis but the mechanism is unknown."3.88Phosphoproteome profiling provides insight into the mechanism of action for carvedilol-mediated cancer prevention. ( Andresen, BT; Cleveland, KH; Huang, KM; Huang, Y; Liang, S; Yeung, S, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cleveland, KH1
Yeung, S1
Huang, KM1
Liang, S1
Andresen, BT1
Huang, Y1

Other Studies

1 other study available for carvedilol and Carcinogenesis

ArticleYear
Phosphoproteome profiling provides insight into the mechanism of action for carvedilol-mediated cancer prevention.
    Molecular carcinogenesis, 2018, Volume: 57, Issue:8

    Topics: Adrenergic beta-Antagonists; Animals; Anticarcinogenic Agents; Carcinogenesis; Carvedilol; Epidermal

2018